Selected article for: "population coverage and SARS protein"

Author: Gao, Ang; Chen, Zhilin; Amitai, Assaf; Doelger, Julia; Mallajosyula, Vamsee; Sundquist, Emily; Segal, Florencia Pereyra; Carrington, Mary; Davis, Mark M.; Streeck, Hendrik; Chakraborty, Arup K.; Julg, Boris
Title: Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-COV-2
  • Cord-id: idp4odj6
  • Document date: 2021_3_15
  • ID: idp4odj6
    Snippet: We describe a physics-based learning model for predicting the immunogenicity of Cytotoxic-T-Lymphocyte (CTL) epitopes derived from diverse pathogens including SARS-CoV-2. The model was trained and optimized on the relative immunodominance of CTL epitopes in Human Immunodeficiency Virus infection. Its accuracy was tested against experimental data from COVID-19 patients. Our model predicts that only some SARS-CoV-2 epitopes predicted to bind to HLA molecules are immunogenic. The immunogenic CTL ep
    Document: We describe a physics-based learning model for predicting the immunogenicity of Cytotoxic-T-Lymphocyte (CTL) epitopes derived from diverse pathogens including SARS-CoV-2. The model was trained and optimized on the relative immunodominance of CTL epitopes in Human Immunodeficiency Virus infection. Its accuracy was tested against experimental data from COVID-19 patients. Our model predicts that only some SARS-CoV-2 epitopes predicted to bind to HLA molecules are immunogenic. The immunogenic CTL epitopes across all SARS-CoV-2 proteins are predicted to provide broad population coverage, but those from the SARS-CoV-2 spike protein alone are unlikely to do so. Our model also predicts that several immunogenic SARS-CoV-2 CTL epitopes are identical to seasonal coronaviruses circulating in the population and such cross-reactive CD8+ T cells can indeed be detected in prepandemic blood donors, suggesting that some level of CTL immunity against COVID-19 may be present in some individuals prior to SARS-CoV-2 infection.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and long broad: 1, 2, 3, 4
    • acute respiratory syndrome and long broad term: 1, 2
    • acute respiratory syndrome and long peptide: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and long range: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low pathogenicity: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and low predict: 1, 2, 3, 4